Soros Fund Management’s Celgene Corp CELG Stock Holding History

Soros Fund Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,178,657	Closed	-$117M	–	199
2019 Q3	$117M	Buy	1,178,657 +361,272	+44%	+$34.3M	3.24%	4
2019 Q2	$75.6M	Buy	817,385 +410,245	+101%	+$39M	1.77%	8
2019 Q1	$38.4M	Buy	+407,140	New	+$35.6M	0.89%	24
2017 Q1	–	Sell	-3,500	Closed	-$405K	–	364
2016 Q4	$405K	Buy	+3,500	New	+$390K	0.01%	154
2014 Q3	–	Sell	-688,000	Closed	-$59.1M	–	439
2014 Q2	$59.1M	Buy	+688,000	New	+$52.3M	0.45%	56

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Soros Fund Management's CELG Position: Q4 2019 in Review

Soros Fund Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,178,657 shares — an estimated $117M sold.

Soros Fund Management first reported a position in CELG in Q2 2014 and held it in 5 quarters. The position peaked at $117M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Soros Fund Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Soros Fund Management sold 1,178,657 Celgene Corp shares in Q4 2019, an estimated $117M.
Soros Fund Management first reported a position in Celgene Corp in Q2 2014 and held it in 5 quarters.
Soros Fund Management's Celgene Corp position peaked at $117M in Q3 2019.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Soros Fund Management's 13F filing for Q4 2019, filed 14 Feb 2020.